Literature DB >> 19960317

APC, T cells, and the immune synapse.

Peter Reichardt1, Bastian Dornbach, Matthias Gunzer.   

Abstract

CD4(+) T cells engage different activating cells during their generation in the bone marrow and thymus and during their homeostasis and activation in the periphery. During these processes, T cells or their precursors establish a molecular platform for communication in the interface between the two cells that is called immune synapse (IS). Here we review the current knowledge about those different IS. Apart from looking at the structure and signalling of the IS from the T cell region, we will also focus on the area of the IS partner, mostly antigen-presenting cells (APC). We will discuss the features of different APC and their role played in the control of the resulting activated or differentiated T cell. We will also demonstrate that despite 10 years of research into the subject, large areas of this field are yet to be explored. This will keep us busy for the years to come - new exciting results lie ahead of us.

Entities:  

Mesh:

Year:  2010        PMID: 19960317     DOI: 10.1007/978-3-642-03858-7_12

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  15 in total

1.  Multimolecular analysis of stable immunological synapses reveals sustained recruitment and sequential assembly of signaling clusters.

Authors:  Lars Philipsen; Thomas Engels; Kerstin Schilling; Slavyana Gurbiel; Klaus-Dieter Fischer; Kerry Tedford; Burkhart Schraven; Matthias Gunzer; Peter Reichardt
Journal:  Mol Cell Proteomics       Date:  2013-06-10       Impact factor: 5.911

Review 2.  Myelin architecture: zippering membranes tightly together.

Authors:  Mostafa Bakhti; Shweta Aggarwal; Mikael Simons
Journal:  Cell Mol Life Sci       Date:  2013-10-29       Impact factor: 9.261

3.  Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells.

Authors:  Lianjing Zhao; Chao Niu; Xiumin Shi; Dongsheng Xu; Min Li; Jiuwei Cui; Wei Li; Jianting Xu; Haofan Jin
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

4.  An in vitro system of autologous lymphocytes culture that allows the study of homeostatic proliferation mechanisms in human naive CD4 T-cells.

Authors:  Isaac Rosado-Sánchez; Amaia González-Magaña; María M Pozo-Balado; Inés Herrero-Fernández; María J Polaino; María M Rodríguez-Méndez; María Francisca González-Escribano; Manuel Leal; Yolanda M Pacheco
Journal:  Lab Invest       Date:  2018-01-18       Impact factor: 5.662

Review 5.  Investigative and clinical applications of synthetic immune synapses.

Authors:  Michael C Milone; Lance C Kam
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-08-23

6.  Immunomodulatory role of high-density lipoproteins: impact on immunosenescence.

Authors:  Anis Larbi; Carl Fortin; Gilles Dupuis; Hicham Berrougui; Abdelouahed Khalil; Tamas Fulop
Journal:  Age (Dordr)       Date:  2014-09-13

7.  Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums.

Authors:  Kodi S Ravichandran
Journal:  J Exp Med       Date:  2010-08-30       Impact factor: 14.307

8.  Logical development of the cell ontology.

Authors:  Terrence F Meehan; Anna Maria Masci; Amina Abdulla; Lindsay G Cowell; Judith A Blake; Christopher J Mungall; Alexander D Diehl
Journal:  BMC Bioinformatics       Date:  2011-01-05       Impact factor: 3.169

Review 9.  Dendritic cell-based vaccine efficacy: aiming for hot spots.

Authors:  Gabriela Andrea Pizzurro; María Marcela Barrio
Journal:  Front Immunol       Date:  2015-03-03       Impact factor: 7.561

10.  CD4⁺ but not CD8⁺ T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice.

Authors:  L Rattazzi; G Piras; M Ono; R Deacon; C M Pariante; F D'Acquisto
Journal:  Transl Psychiatry       Date:  2013-07-09       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.